Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Incidence / Prevalence & Ulcerative colitis (UC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Ulcerative colitis (UC) affects 5 million people worldwide in 2023
Le Berre et al. 2023 Lancet 402: 571-584
Wangchuk et al. 2024 Trends in Pharmacological Sciences 45(10): 892-903

Ulcerative colitis (UC) is predominantly a disease of Western industrialized nations. However, the incidence and hospitalization rates are rapidly increasing in emerging countries such as China, India, and Latin America
Buie et al. 2023 Clin. Gastroenterol. Hepatol. 21: 2211-2221
Le Berre et al. 2023 Lancet 402: 571-584

The incidence of Ulcerative colitis (UC) is increasing rapidly in Asia. For example, data from a systematic review of epidemiological studies indicated the incidence rates for [IBD](brain://BZvzVH9I-0OVn4NWy…

References (Sources)

A systematic review of epidemiology and risk factors associated with Chinese inﬂammatory bowel disease
Cui & Yuan 2018 Frontiers of Medicine 5: 183
Global hospitalization trends for Crohn's disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses
Buie et al. 2023 Clin. Gastroenterol. Hepatol. 21: 2211-2221
Review
Nutritional Interventions for the Treatment of IBD: Current Evidence and Controversies
Pigneur & Ruemmele 2019 Ther. Adv. Gastroenterol. 12: 175628481989053
Potential inﬂuential factors on incidence and prevalence of inﬂammatory bowel disease in mainland China
Qiao & Ran 2020 JGH Open 4(1): 11-15
Review
Probiotics for induction of remission in ulcerative colitis
Mallon et al. 2007 Cochrane Database Syst Rev doi: 10.1002/14651858.CD005573.pub2.
Ulcerative colitis
Le Berre et al. 2023 Lancet 402: 571-584
Review
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Wangchuk et al. 2024 Trends in Pharmacological Sciences 45(10): 892-903

AI Chat

7/1/2026

Chat with our artificial intelligence: